VSTM - 3.84 Pre-market now at 5.31/5.34 Verastem's Phase 3 DUO Study Showed Statistically Significant Improvement BZ: Verastem's Duvelisib Receives Fast Track Designation from the FDA http://stockcharts.com/c-sc/sc?s=VSTM&p=D&b=5&g=0&i=t74800651830&r=1504699088295 http://stockcharts.com/c-sc/sc?s=VSTM&p=W&b=5&g=0&i=t06565384318&r=1504699065026